KMT2A and acute myeloid leukemia: Previous studies have shown that FTO is abnormally upregulated in certain subtypes of AML, such as t (11q23)/MLL rearrangement, t (15; 17), FLT3-ITD, and/or NPM1-mutated AML [30].